Significant Drug Launches in 2019: A BCC Research Analysis and Insights on Pharmaceutical Industry

Target Date - September 2019| Publisher - BCC Publishing| Code - PHM220A

Significant Drug Launches in 2019: A BCC Research Analysis and Insights on Pharmaceutical Industry

Notify Me

Report Includes
  • Information on the top potential drug launches by pharma companies in 2019
  • Knowledge about drug, mechanism of action, and briefing of clinical evidences
  • Detailed information and insights on the drug Upadacitinib which is manufactured by AbbVie Inc. , Ultomiris (ravulizumab-cwvz) a humanized monoclonal antibody manufactured by Alexion Pharmaceuticals Inc. and many more
  • Insights into regulatory approvals, market scope, and analysis of pipeline molecules
  • Detailed profiles of the companies and competitors related to the industry
Get Notified when New Reports are published
CUSTOM

 

MEMBERSHIP